Peripheral blood gene expression profile of atherosclerotic coronary artery disease in patients of different ethnicity in Malaysia

Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease, N Engl J Med, 352, 1685, 10.1056/NEJMra043430

Arnett, 2007, Circulation, 115, 2878, 10.1161/CIRCULATIONAHA.107.183679

Bijnens, 2006, Genome-wide expression studies of atherosclerosis. Critical issues in methodology, analysis, interpretation of transcriptomics data, Arterioscler Thromb Vasc Biol, 26, 1226, 10.1161/01.ATV.0000219289.06529.f1

Debey, 2006, A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials, Genomics, 87, 653, 10.1016/j.ygeno.2005.11.010

Fan, 2005, The transcriptome in blood: challenges and solutions for robust expression profiling, Curr Mol Med, 5, 3, 10.2174/1566524053152861

Barnes, 2005, Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms, Nucleic Acids Res, 33, 5914, 10.1093/nar/gki890

Wright, 2008, Characterization of globin RNA interference in gene expression profiling of whole-blood samples, Clin Chem, 54, 396, 10.1373/clinchem.2007.093419

Orr, 2009, Sample size estimation while controlling false discovery rate for microarray experiments using the ssize.fdr package, R J, 1, 47, 10.32614/RJ-2009-019

Liu, 2007, Quick calculation for sample size while controlling false discovery rate with application to microarray analysis, Bioinformatics, 23, 739, 10.1093/bioinformatics/btl664

Dennis, 2003, Database for annotation, visualization, and integrated discovery, Genome Biol, 4, P3, 10.1186/gb-2003-4-5-p3

Huang, 2009, Systematic and integrative analysis of large gene lists using DAVID, Bioinform Resour – Nat Protoc, 4, 44, 10.1038/nprot.2008.211

Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J R Stat Soc B (Methodological), 57, 289, 10.1111/j.2517-6161.1995.tb02031.x

Kai, 1998, Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes, J Am Coll Cardiol, 32, 368, 10.1016/S0735-1097(98)00250-2

Blankenberg, 2003, AtheroGene Investigators. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease, Circulation, 107, 1579, 10.1161/01.CIR.0000058700.41738.12

Tayebjee, 2005, Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease, Am J Cardiol, 96, 339, 10.1016/j.amjcard.2005.03.072

Galis, 2002, Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly, Circ Res, 90, 251, 10.1161/res.90.3.251

Fukuda, 2006, Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris, Am J Cardiol, 97, 175, 10.1016/j.amjcard.2005.08.020

Wang, 2001, Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis, Clin Sci (Lond), 101, 87, 10.1042/CS20000317

Kim, 2002, The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina, Yonsei Med J, 43, 473, 10.3349/ymj.2002.43.4.473

Haberbosch, 2005, Gelatinase B (C-1652 T) polymorphism in relation to ischaemic heart disease, Scand J Clin Lab Invest, 65, 513, 10.1080/00365510500206575

Wæhre, 2003, Hydroxymethylglutaryl coenzyme A reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease, J Am Coll Cardiol, 41, 1460, 10.1016/S0735-1097(03)00263-8

Victor, 2009, Oxidative stress, endothelial dysfunction and atherosclerosis, Curr Pharm Des, 15, 2988, 10.2174/138161209789058093

Ballinger, 2002, Mitochondrial integrity and function in atherogenesis, Circulation, 106, 544, 10.1161/01.CIR.0000023921.93743.89

Chrissobolis, 2008, Glutathione peroxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction, Hypertension, 51, 872, 10.1161/HYPERTENSIONAHA.107.103572

Chiang, 2011, Lysosomal thiol reductase negatively regulates autophagy by altering glutathione synthesis and oxidation, Free Radic Biol Med, 51, 688, 10.1016/j.freeradbiomed.2011.05.015

Libby, 2005, Pathophysiology of coronary artery disease, Circulation, 111, 3481, 10.1161/CIRCULATIONAHA.105.537878

Archacki, 2003, Identification of new genes differentially expressed in coronary artery disease by expression profiling, Physiol Genomics, 15, 65, 10.1152/physiolgenomics.00181.2002

Feezor, 2004, Whole blood and leukocyte RNA isolation for gene expression analyses, Physiol Genomics, 19, 247, 10.1152/physiolgenomics.00020.2004

Sluimer, 2007, Dead or alive: gene expression profiles of advanced atherosclerotic plaques from autopsy and surgery, Physiol Genomics, 30, 335, 10.1152/physiolgenomics.00076.2007

Taurino, 2010, Gene expression profiling in whole blood of patients with coronary artery disease, Clin Sci (Lond), 119, 335, 10.1042/CS20100043